chr22-50626933-C-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000487.6(ARSA):​c.585G>T​(p.Trp195Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0685 in 1,613,172 control chromosomes in the GnomAD database, including 4,413 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.051 ( 275 hom., cov: 33)
Exomes 𝑓: 0.070 ( 4138 hom. )

Consequence

ARSA
NM_000487.6 missense

Scores

6
10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13O:1

Conservation

PhyloP100: 1.05
Variant links:
Genes affected
ARSA (HGNC:713): (arylsulfatase A) The protein encoded by this gene hydrolyzes cerebroside sulfate to cerebroside and sulfate. Defects in this gene lead to metachromatic leucodystrophy (MLD), a progressive demyelination disease which results in a variety of neurological symptoms and ultimately death. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Dec 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004769802).
BP6
Variant 22-50626933-C-A is Benign according to our data. Variant chr22-50626933-C-A is described in ClinVar as [Benign]. Clinvar id is 93125.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-50626933-C-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0754 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ARSANM_000487.6 linkuse as main transcriptc.585G>T p.Trp195Cys missense_variant 3/8 ENST00000216124.10 NP_000478.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ARSAENST00000216124.10 linkuse as main transcriptc.585G>T p.Trp195Cys missense_variant 3/81 NM_000487.6 ENSP00000216124 P1

Frequencies

GnomAD3 genomes
AF:
0.0511
AC:
7779
AN:
152216
Hom.:
276
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0150
Gnomad AMI
AF:
0.0833
Gnomad AMR
AF:
0.0340
Gnomad ASJ
AF:
0.0810
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.0151
Gnomad FIN
AF:
0.0780
Gnomad MID
AF:
0.0665
Gnomad NFE
AF:
0.0772
Gnomad OTH
AF:
0.0507
GnomAD3 exomes
AF:
0.0529
AC:
13189
AN:
249174
Hom.:
491
AF XY:
0.0535
AC XY:
7243
AN XY:
135288
show subpopulations
Gnomad AFR exome
AF:
0.0127
Gnomad AMR exome
AF:
0.0277
Gnomad ASJ exome
AF:
0.0750
Gnomad EAS exome
AF:
0.000164
Gnomad SAS exome
AF:
0.0222
Gnomad FIN exome
AF:
0.0752
Gnomad NFE exome
AF:
0.0768
Gnomad OTH exome
AF:
0.0586
GnomAD4 exome
AF:
0.0703
AC:
102707
AN:
1460838
Hom.:
4138
Cov.:
34
AF XY:
0.0691
AC XY:
50188
AN XY:
726720
show subpopulations
Gnomad4 AFR exome
AF:
0.0110
Gnomad4 AMR exome
AF:
0.0281
Gnomad4 ASJ exome
AF:
0.0691
Gnomad4 EAS exome
AF:
0.000151
Gnomad4 SAS exome
AF:
0.0224
Gnomad4 FIN exome
AF:
0.0718
Gnomad4 NFE exome
AF:
0.0806
Gnomad4 OTH exome
AF:
0.0601
GnomAD4 genome
AF:
0.0511
AC:
7778
AN:
152334
Hom.:
275
Cov.:
33
AF XY:
0.0502
AC XY:
3738
AN XY:
74496
show subpopulations
Gnomad4 AFR
AF:
0.0150
Gnomad4 AMR
AF:
0.0339
Gnomad4 ASJ
AF:
0.0810
Gnomad4 EAS
AF:
0.000386
Gnomad4 SAS
AF:
0.0153
Gnomad4 FIN
AF:
0.0780
Gnomad4 NFE
AF:
0.0772
Gnomad4 OTH
AF:
0.0502
Alfa
AF:
0.0709
Hom.:
701
Bravo
AF:
0.0458
TwinsUK
AF:
0.0747
AC:
277
ALSPAC
AF:
0.0825
AC:
318
ESP6500AA
AF:
0.0170
AC:
75
ESP6500EA
AF:
0.0771
AC:
663
ExAC
AF:
0.0527
AC:
6402
Asia WGS
AF:
0.00808
AC:
28
AN:
3478
EpiCase
AF:
0.0796
EpiControl
AF:
0.0787

ClinVar

Significance: Benign
Submissions summary: Benign:13Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Nov 23, 2015- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Metachromatic leukodystrophy Benign:4Other:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaMar 06, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsJun 29, 2017- -
Benign, criteria provided, single submitterclinical testingPars Genome LabJun 15, 2021- -
not provided, no classification providedin vitroGelb Laboratory, University of Washington-- -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015This variant is associated with the following publications: (PMID: 31836585, 28670130, 8897113) -
Benign, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo ClinicJul 25, 2017- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Citrullinemia Benign:1
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Uncertain
-0.080
CADD
Pathogenic
26
DANN
Uncertain
0.99
DEOGEN2
Benign
0.23
T;T;T;.;T
Eigen
Benign
0.0048
Eigen_PC
Benign
0.041
FATHMM_MKL
Benign
0.70
D
LIST_S2
Uncertain
0.86
.;.;.;D;D
MetaRNN
Benign
0.0048
T;T;T;T;T
MetaSVM
Benign
-0.32
T
MutationTaster
Benign
1.0
D;D;D;D;D;D;D
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-0.73
N;N;N;N;N
REVEL
Uncertain
0.42
Sift
Benign
0.036
D;D;D;D;D
Sift4G
Uncertain
0.032
D;D;D;T;D
Vest4
0.49
ClinPred
0.010
T
GERP RS
3.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
gMVP
0.90

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs6151415; hg19: chr22-51065361; COSMIC: COSV53350176; COSMIC: COSV53350176; API